Home/Filings/4/0001447028-20-000152
4//SEC Filing

McElhaugh Michael J. 4

Accession 0001447028-20-000152

CIK 0001447028other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 4:33 PM ET

Size

9.6 KB

Accession

0001447028-20-000152

Insider Transaction Report

Form 4
Period: 2020-12-14
McElhaugh Michael J.
DirectorInterim President & CEO
Transactions
  • Sale

    Common Stock

    2020-12-14$5.00/sh10,000$50,0321,327,457 total
  • Sale

    Common Stock

    2020-12-14$5.00/sh30,000$150,0001,337,457 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020.

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeother

Related Parties

1
  • filerCIK 0001635326

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:33 PM ET
Size
9.6 KB